Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/26 09:20 | 9/30/26 | XENE | Health | Drug | Pharmaceutical Preparations | Kelly Thomas Patrick | O | CFO | 1 | P | 560 | 37.32 | 0 | 15 | 15 | D | ||||||||||||||||
10/1/26 09:19 | 9/30/26 | XENE | Health | Drug | Pharmaceutical Preparations | Mortimer Ian | DO | P,CEO | 1 | P | 1,121 | 37.38 | 0 | 30 | 88 | 64 | D | |||||||||||||||
9/3/26 20:26 | 9/1/26 | XENE | Health | Drug | Pharmaceutical Preparations | Svoronos Dawn | D | 1 | M.d | 42 | 8.15 | 0 | 5 | 20 | 31 | D | ||||||||||||||||
8/31/26 21:59 | 8/28/26 | XENE | Health | Drug | Pharmaceutical Preparations | Kenney Christopher John | O | Chief Me | 1 | S | -426 | 60.25 | 0 | -7 | -100 | 0 | D | |||||||||||||||
8/13/26 16:33 | 8/11/26 | XENE | Health | Drug | Pharmaceutical Preparations | Gannon Steven | D | 1 | S | -641 | 64.06 | 0 | -10 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |